Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions
NCT00970333
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer Disease
Parkinson Disease
Multiple Sclerosis
Interventions
DRUG:
[18F]-FEPPA
Sponsor
Institute for Neurodegenerative Disorders